🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

951 results for “Eli” Clear

  1. Investigating the pharmacokinetics of petrelintide using different drug product concentrations in participants with a BMI ≥27.0 kg/m2

    Zealand Pharma A/S

    Weight reduction

    phase 1 other active

    1 trial

  2. Irinotecan liposome II combination therapy regimen

    Chongqing Claruvis Pharmaceutical Co.,

    Non-Muscle Invasive Bladder Urothelial Carcinoma

    phase 1 small molecule active

    1 trial

  3. J1O-MC-JZHD: A Phase 1 Study of Aurora Kinase A Inhibitor LY3295668 Erbumine as a Single Agent and in Combination in Patients With Relapsed/Refractory Neuroblastoma

    Eli Lilly Co.

    Neuroblastoma

    phase 1 other active

    1 trial

  4. Keverprazan

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    phase 1 small molecule active

    1 trial

  5. LCAR-M23 cells

    Nanjing Legend Biotech Co.

    Epithelial Ovarian Cancer

    phase 1 mab terminated

    1 trial

  6. LY3039478

    Eli Lilly and Company

    Advanced Solid Tumor

    phase 1 small molecule completed

    1 trial

  7. LY3053102

    Eli Lilly and Company

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  8. LY3209590 (SC)

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial

  9. LY3484356

    Eli Lilly and Company

    Breast Neoplasms

    phase 1 small molecule active

    1 trial

  10. LY3493269

    Eli Lilly and Company

    Healthy

    phase 1 small molecule terminated

    1 trial

  11. LY3493269 - SC

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial

  12. LY3532226

    Eli Lilly and Company

    Obesity

    phase 1 small molecule completed

    1 trial

  13. LY3537021

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial

  14. LY3819469

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial

  15. LY4006896

    Eli Lilly and Company

    Parkinson Disease

    phase 1 small molecule active

    1 trial

  16. Lifestyle counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Adherence

    phase 1 other completed

    1 trial

  17. Lobeline

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 1 small molecule active

    1 trial

  18. Midazolam

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Delirium

    phase 1 small molecule active

    1 trial

  19. Minnelide™Capsules

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  20. Multiple Ascending Dose Study of LY4256984 in Participants with Sporadic Amyotrophic Lateral Sclerosis

    Eli Lilly Co.

    Sporadic Amyotrophic Lateral Sclerosis

    phase 1 other active

    1 trial

  21. NX-1607

    Nurix Therapeutics

    Ovarian Cancer, Epithelial

    phase 1 small molecule active

    1 trial

  22. NeoTISLEGA - A phase Ib trial evaluating the safety and activity of neoadjuvant combination of tislelizumab plus FLOT for resectable esophagogastric adenocarcinoma

    The George Institute

    resectable esophagogastric adenocarcinoma

    phase 1 other active

    1 trial

  23. Olaratumab

    Eli Lilly and Company

    Malignancy

    phase 1 mab completed

    1 trial

  24. Olomorasib

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources